2-METHYL-2-(3-METHYL-4-NITRO-1H-PYRAZOL-1-YL)PROPANAMIDE, 95.0%, 1g

4,5-Difluoro-2-methoxyphenylacetonitrile, 95+%, 250mg

6-Bromothiazolo[4,5-c]pyridine, 95.0%, 50mg

2,4,5-Trimethylaniline, 97.0%, 10g

4,4-Dimethyl-piperidine, 95.0%, 5g

N-methyl-1-(5-methyl-1,3,4-oxadiazol-2-yl)methanamine, 95.0%, 5g

3-Cyano-4-oxo-piperidine-1-carboxylic acid tert-butyl ester, 95.0%, 25g

3-Methoxysalicylic acid, min. 97%, for synthesis, 25 g, glass packaging

Ethyl trifluoropyruvate, 97.0%, 5g

1,1-Diphenylthiourea, 25g

6-Bromoquinoline-4-carbaldehyde, 95.0%, 100mg

1-(Bromomethyl)-4-methoxy-2-nitrobenzene, 95.0%, 1g

(6-Methylpyridazin-3-yl)methanol, 95.0%, 250mg